Fibroma MRI

Revision as of 19:23, 23 February 2016 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Fibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Fibroma from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Fibroma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroma MRI

CDC on Fibroma MRI

Fibroma MRI in the news

Blogs on Fibroma MRI

Directions to Hospitals Treating Fibroma

Risk calculators and risk factors for Fibroma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Key MRI Findings in Fibroma

  • Signal characteristics include
  • T1: fibromas usually demonstrate homogeneous low signal intensity
  • T2
  • Fibromas appear as well-circumscribed masses with low signal intensity
  • May contain scattered hyperintense areas representing oedema or cystic degeneration.
  • A band of T2 hypointensity separating the tumour from the uterus on all imaging planes is also considered a characteristic feature
  • T1 C+ (Gd): usually shows heterogenous enhancement

MRI Examples of Fibroma

References


Template:WikiDoc Sources